FR2788531B1 - Nouveaux polypeptides derives de la proteine jnk3 humaine, leurs variants, les sequences nucleotidiques correspondantes, et leurs utilisations - Google Patents

Nouveaux polypeptides derives de la proteine jnk3 humaine, leurs variants, les sequences nucleotidiques correspondantes, et leurs utilisations

Info

Publication number
FR2788531B1
FR2788531B1 FR9900586A FR9900586A FR2788531B1 FR 2788531 B1 FR2788531 B1 FR 2788531B1 FR 9900586 A FR9900586 A FR 9900586A FR 9900586 A FR9900586 A FR 9900586A FR 2788531 B1 FR2788531 B1 FR 2788531B1
Authority
FR
France
Prior art keywords
variants
nucleotide sequences
corresponding nucleotide
novel polypeptides
polypeptides derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9900586A
Other languages
English (en)
Other versions
FR2788531A1 (fr
Inventor
Francine Desanlis
Alain Fournier
Isabelle Maury
Liu Oing Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9900586A priority Critical patent/FR2788531B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to AU30560/00A priority patent/AU3056000A/en
Priority to EP00900608A priority patent/EP1144651A1/fr
Priority to CA002358914A priority patent/CA2358914A1/fr
Priority to PCT/FR2000/000104 priority patent/WO2000043524A1/fr
Priority to NZ512986A priority patent/NZ512986A/xx
Priority to JP2000594932A priority patent/JP2002534982A/ja
Priority to IL14395000A priority patent/IL143950A0/xx
Publication of FR2788531A1 publication Critical patent/FR2788531A1/fr
Priority to US09/909,650 priority patent/US6649388B2/en
Priority to NO20013568A priority patent/NO20013568L/no
Application granted granted Critical
Publication of FR2788531B1 publication Critical patent/FR2788531B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
FR9900586A 1999-01-20 1999-01-20 Nouveaux polypeptides derives de la proteine jnk3 humaine, leurs variants, les sequences nucleotidiques correspondantes, et leurs utilisations Expired - Fee Related FR2788531B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR9900586A FR2788531B1 (fr) 1999-01-20 1999-01-20 Nouveaux polypeptides derives de la proteine jnk3 humaine, leurs variants, les sequences nucleotidiques correspondantes, et leurs utilisations
IL14395000A IL143950A0 (en) 1999-01-20 2000-01-19 Polypeptides derived from jnk3
CA002358914A CA2358914A1 (fr) 1999-01-20 2000-01-19 Polypeptides derives de jnk3
PCT/FR2000/000104 WO2000043524A1 (fr) 1999-01-20 2000-01-19 Polypeptides derives de jnk3
NZ512986A NZ512986A (en) 1999-01-20 2000-01-19 Polypeptides derived from JNK3
JP2000594932A JP2002534982A (ja) 1999-01-20 2000-01-19 Ｊｎｋ３から誘導されるポリペプチド
AU30560/00A AU3056000A (en) 1999-01-20 2000-01-19 Polypeptides derived from jnk3
EP00900608A EP1144651A1 (fr) 1999-01-20 2000-01-19 Polypeptides derives de jnk3
US09/909,650 US6649388B2 (en) 1999-01-20 2001-07-19 Polypeptides derived from JNK3
NO20013568A NO20013568L (no) 1999-01-20 2001-07-19 Polypeptider avledet fra JNK3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9900586A FR2788531B1 (fr) 1999-01-20 1999-01-20 Nouveaux polypeptides derives de la proteine jnk3 humaine, leurs variants, les sequences nucleotidiques correspondantes, et leurs utilisations

Publications (2)

Publication Number Publication Date
FR2788531A1 FR2788531A1 (fr) 2000-07-21
FR2788531B1 true FR2788531B1 (fr) 2003-01-31

Family

ID=9541039

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9900586A Expired - Fee Related FR2788531B1 (fr) 1999-01-20 1999-01-20 Nouveaux polypeptides derives de la proteine jnk3 humaine, leurs variants, les sequences nucleotidiques correspondantes, et leurs utilisations

Country Status (1)

Country Link
FR (1) FR2788531B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514745B1 (en) * 1993-07-19 2003-02-04 The Regents Of The University Of California Oncoprotein protein kinase
CA2148898A1 (fr) * 1994-05-09 1995-11-10 John M. Kyriakis Proteine p54 activee par le stress

Also Published As

Publication number Publication date
FR2788531A1 (fr) 2000-07-21

Similar Documents

Publication Publication Date Title
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
ATE551362T1 (de) Peptide, die den blutzuckergehalt senken
BR0014514A (pt) Enzimas da via de destinação lisossomal
WO2002044320A3 (fr) Genes humains de l'elongase, leurs utilisations et composes destines a leur modulation
FR2845388B1 (fr) Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
FR2788531B1 (fr) Nouveaux polypeptides derives de la proteine jnk3 humaine, leurs variants, les sequences nucleotidiques correspondantes, et leurs utilisations
ITTO20010517A0 (it) Cellule progenitrici vascolari umane.
FR2775477B1 (fr) Nouveaux derives diarylmethylene heterocycliques, leurs procedes de preparation et leurs utilisations en therapeutique
GB2349150B (en) Expression of DNA or proteins in C. Elegans
BR0014167A (pt) Proteìna iren, sua preparação e aplicação
MA24582A1 (fr) Nouveaux derives de 4-hydroxy-2h-1-(thio) pyran-2-ones, leurs preparations et leurs utilisations comme rodonticides.
IT1316400B1 (it) Complesso integrale giogo di supporto e imbracatore.
WO2001014415A3 (fr) Gènes egfh2 et produits géniques
ATE296789T1 (de) Spezifisch markierte proteine, aminosäure und biochemische vorläufer
FR2834289B1 (fr) Derives de benzothiazole-4,7-diones et benzooxazole-4,7- diones, leur preparation et leurs applications therapeutiques
IS4987A (is) PTX næm G prótein, framleiðsla þeirra og notkun
DE10082298D2 (de) Chimäre Proteine
DZ2803A1 (fr) Polypeptide de la protéine c humaine.
FR2794371B1 (fr) Fragments proteiquespolyepitopiques, leur obtention et leurs utilisations notamment en vaccination
WO2001025430A3 (fr) Nouvelles proteines membranaires humaines
FR2785619B1 (fr) GENE tfIIIA DE CANDIDA ALBICANS (CatfIIIA) ET LA PROTEINE CODEE CATFIIIA
ES1042220Y (es) Taco de artrodesis vertebral.
FR2785618B1 (fr) GENE HUMAIN htfIIIA ET LA PROTEINE CODEE hTFIIIA
ES1033626Y (es) Muñeco imitador de actos fisiologicos.
FR2812656B1 (fr) Acides nucleiques et proteines d'e. coli pathogenes, et leurs utilisations

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20150930